What is it that drives basic research? What is it like... pushing the frontier of knowledge? Observing, deriving, testing models... There are few places in the world that allow you to boldly embrace your #curiosity. Learn more about one of them: https://lnkd.in/dTbw8Ge
Research Institute of Molecular Pathology (IMP)
Forschung
A leading basic research institute addressing fundamental questions in molecular biology. Part of Vienna BioCenter.
Info
The Research Institute of Molecular Pathology (IMP) in Vienna is a basic biomedical research institute largely sponsored by Boehringer Ingelheim. With over 200 scientists from 40 countries, the IMP is committed to scientific discovery of fundamental molecular and cellular mechanisms underlying complex biological phenomena. Research areas include cell and molecular biology, microscopy, immunology and cancer, developmental biology, chromosome biology, and computational biology.
- Website
-
http://www.imp.ac.at
Externer Link zu Research Institute of Molecular Pathology (IMP)
- Branche
- Forschung
- Größe
- 201–500 Beschäftigte
- Hauptsitz
- Vienna
- Art
- Einzelunternehmen (Gewerbe, Freiberufler etc.)
- Gegründet
- 1985
- Spezialgebiete
- Molecular Biology, Disease Mechanisms, Computational biology, Immunology, Cell Biology, Chromosome Biology, Gene Regulation, Developmental Biology und Microscopy
Orte
-
Primär
Wegbeschreibung
Campus-Vienna-Biocenter 1
Vienna, 1030, AT
Beschäftigte von Research Institute of Molecular Pathology (IMP)
Updates
-
🎉 Congratulations to our postdocs Victoria Deneke (Pauli lab) and Matthias Vorländer (Plaschka lab) on securing funding through the Austrian Science Fund FWF’s ESPRIT Program! Both researchers received prestigious postdoctoral fellowships from the FWF, which will support their projects for three years. 🔬 Victoria Deneke will use biochemical, genetic, and structural techniques to characterise the vertebrate fertilisation complex that the lab has recently identified. 🔬 Matthias Vorländer will leverage his structural biology expertise to get a near-atomic look at how cells cut and combine RNA during trans-splicing. Read more about their projects here: https://lnkd.in/dyqFZbxd Vienna BioCenter
-
-
🌟 Relive the Birnstiel Award acceptance talks with us! In November, we will have the pleasure of welcoming our 2024 Birnstiel Awardees to the IMP, where they’ll present their groundbreaking #research. We can’t wait to hear about their discoveries and celebrate their achievements! While we anticipate this year's presentations, let’s take a moment to revisit some of the inspiring highlights from past awardees. The most popular talk from 2022 is by Michael Skinnider, recognised for his PhD work on innovative computational methods to interpret mass spectrometry data. Michael completed a MD/PhD at the The University of British Columbia, with Leonard Foster. In his doctoral research, Michael used machine learning to identify proteins that physically interact in living tissues. This work revealed how inherited mutations, present in every cell in the body, can cause dysfunction in just one tissue. Michael then developed an #AI platform capable of determining the chemical structures of small molecules using mass spectrometry, showcasing its potential to automatically detect emerging drugs of abuse. Michael is now assistant professor at Princeton University. ➡️ Watch the talk here: https://lnkd.in/dVdhGPca #PhD #Award #LifeSciences
-
-
Some reflections on the exceptional media uptake of our recent fertilisation paper and how it came to be:
What a splash! We managed to get last week’s sperm-egg-contact story into The New York Times, The Washington Post, Euronews, India Today, Geo Magazine, Science Magazine, Nature Magazine, and dozens more! This insane media coverage was probably the biggest of any IMP paper to date. Sex sells? Groundbreaking science? Yes, as well. But also solid media relations work. Time for sharing some #SciCom insights… FIRST: the quality of the research, of course. At the Research Institute of Molecular Pathology (IMP), we are lucky to have incredibly gifted and hardworking scientists who deliver 60 to 90 publications each year – about a third of those are with corresponding authors from the IMP. In our case, kudos to Andrea Pauli, Victoria Deneke, and Andreas Blaha on behalf of a big team of contributors. SECOND (shifting to comms now): spot the potential. For most of our papers, we target specialist audiences via our own channels, especially our highly successful social media. In this case, however, something was different. #Fertilisation is relatable even to lay/laid people, and the fundamental nature of the discovery alongside the high-calibre journal (Cell by Cell Press) that published the paper also weighed in. So editorial media it would be for this one! THIRD: find a narrative. You only have one chance to leave a first impression, and this holds especially true for media pitches and press releases. Do we focus on the practical use of #AlphaFold (#NobelPrize from the previous week)? Or do we focus on the machinery that operates like lock and key on #sperm and #eggs of #vertebrates? We chose the latter, in a slimmed-down version: first contact between egg and sperm! The kiss of life! FOURTH: prepare your visuals. We were lucky to have a great set of images from our scientists and their collaborators at Osaka University. We picked the best (in terms of aesthetics, not scientific information content) and prepared a handy image catalogue. We also liaised with videographer Philipp Dexheimer, PhD to shoot an explainer video. Image catalogue including download link, video, and press release would be our pitch package. FIFTH: pitch. And pitch more. We finally made use of our prohibitively expensive subscription to a journalist directory and individually contacted media representatives that we thought would be genuinely interested. It’s 2024, people drown in information, focus is key here. Start with wire services and press offices of scientific journals; then daily papers and broadcasting; finish with magazines. Don’t forget the freelancers! They need to eat, too. SIXTH: be responsive. Nobody likes to wait, and journalists typically work under time pressure. Whoever got back to communications by email or phone got a reply within (few!) minutes – practically around the clock. We had the calendar of our principal investigator, so we could schedule and confirm interviews quickly. Which takes us back to the stars of the show, the authors - Communications out.
-
-
📣 Ready for a new opportunity? We're #hiringnow! Whether you’re exploring your next steps in #research, #animalcare, #HR, or #administration we have openings for you. 🔍 Check out our latest positions: https://lnkd.in/dB7gWfQV
-
-
Research Institute of Molecular Pathology (IMP) hat dies direkt geteilt
Flashback from #EACR2024: it was great meeting Anais Elewaut, PhD student from Anna Obenauf Lab, Research Institute of Molecular Pathology (IMP)! Thank you SO much, Anais, for sharing your story of passion for immuno-oncology, embracing curiosity-driven approach & pushing the boundaries with such a great energy and collaborative spirit! We know it was a busy meeting for you also presenting at EACR Drug Resistance Symposium session - really appreciate your time to chat with Illumina crew! Check it out on #BreakThrough #ResearchGateResearchGate page (in 2 parts!) [Watch Now]
-
🌟 Relive the Birnstiel Award acceptance talks with us! In November, we will have the pleasure of welcoming our 2024 Birnstiel Awardees to the IMP, where they’ll present their groundbreaking research. We can’t wait to hear about their discoveries and celebrate their achievements! While we anticipate this year's presentations, let’s take a moment to revisit some of the inspiring highlights from past awardees. The most popular talk from 2021 is by Kristina Stapornwongkul, awarded for her PhD work on the development of an artificial morphogen system to pattern the wing of the fruit fly Drosophila. Kristina pursued her doctoral research in the lab of Jean-Paul Vincent at UCL and The Francis Crick Institute, and is currently a postdoctoral researcher at EMBL Barcelona. During her PhD, Kristina demonstrated that protein gradients can form through diffusion, highlighting the role of extracellular matrix components. ➡️ Watch the talk here: https://lnkd.in/ezRwS6GK #PhD #Award #LifeSciences
-
-
🔬 Egg and sperm use a "lock-and-key" mechanism to initiate #fertilisation. Andrea Pauli’s lab at the IMP with collaborators have revealed the formation of a fertilisation complex, shedding light on the very first contact between egg and sperm. Genetic studies have previously identified many proteins involved in the process, but no direct evidence had shown how these factors bind or form complexes to function as a “lock-and-key” mechanism. Their findings, drawn from studies in zebrafish, mice, and human cells, are published in the journal Cell. ➡️ Read more: https://lnkd.in/eUavEHKK ➡️ Paper: https://lnkd.in/ecVBweBD Vienna BioCenter, Cell Press
-
-
🔬 Anna Obenauf, Senior Group Leader at the IMP, has joined the ADAPTMET consortium! The EU-funded project aims at training the next generation of #metastasis researchers. ✅ ADAPTMET is supported by €4.4 million in funding, and will provide cutting-edge, multidisciplinary training to 15 young scientists over the next four years. This project is led by the IRB Barcelona, and brings together leading European research institutes. This marks the second round of funding under the EU’s Innovative Training Networks (ITN) programme, part of the Marie Sklodowska-Curie Actions, building on the success of the EVOMET ITN network. ➡️ Learn more: https://lnkd.in/dvWTy75y #Cancer #CancerResearch #Metastasis #MetastasisResearch #Research
-
-
👩🔬Curious about #fertilisation and #development? Then join Andrea Pauli’s research group through the Vienna BioCenter PhD Program! 🗓️ Application deadline: Today! (or apply in Spring). This is your chance to become one of her #PhD students and contribute to cutting-edge research. Apply now: https://lnkd.in/d972qPf 🎥 Learn more about Andrea Pauli’s research in this 'Scientist Snapshot': https://lnkd.in/debn_qvh Vienna BioCenter
-